NewcelX prices USD 1.4 million private placement at USD 4.03 per sharePUBT·Jul 31 at 08:00 AMNCEL-7.08%ELDN-4.32%
NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036PUBT·Jul 15 at 08:03 AMNCEL-7.08%
NewcelX appoints diabetes researcher Camillo Ricordi to scientific advisory boardPUBT·Jul 8 at 08:15 AMNCEL-7.08%ELDN-4.32%
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board | NCEL Stock NewsStockTitan·Jul 8 at 12:15 AMNCEL-7.08%ELDN-4.32%
NewcelX reports successful FDA pre-IND meeting for NCEL-101 type 1 diabetes trial planPUBT·Jul 2 at 01:32 PMNCEL-7.08%ELDN-4.32%
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes | NCEL Stock NewsStockTitan·Jul 1 at 12:30 AMNCEL-7.08%ELDN-4.32%
